BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36233409)

  • 1. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.
    Komarnicki P; Musiałkiewicz J; Stańska A; Maciejewski A; Gut P; Mastorakos G; Ruchała M
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
    Modlin IM; Bodei L; Kidd M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use.
    Tsoli M; Koumarianou A; Angelousi A; Kaltsas G
    Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101785. PubMed ID: 37336711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review).
    Ciobanu OA; Martin S; Fica S
    Exp Ther Med; 2021 Dec; 22(6):1479. PubMed ID: 34765020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide.
    Bevere M; Masetto F; Carazzolo ME; Bettega A; Gkountakos A; Scarpa A; Simbolo M
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in neuroendocrine tumors.
    Eriksson B; Oberg K; Stridsberg M
    Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
    van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
    Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.
    Oberg K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):109-12. PubMed ID: 22584714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
    Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
    Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of neuroendocrine tumors.
    d'Herbomez M; Coppin L; Bauters C; Rouaix-Emery N; Carnaille B; Do Cao C
    Ann Biol Clin (Paris); 2016 Dec; 74(6):669-679. PubMed ID: 27758762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review.
    Kalligeros M; Diamantopoulos L; Toumpanakis C
    Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
    Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
    Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
    Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
    World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry of neuroendocrine tumours.
    de Herder WW
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine tumor biomarkers: current status and perspectives.
    Modlin IM; Oberg K; Taylor A; Drozdov I; Bodei L; Kidd M
    Neuroendocrinology; 2014; 100(4):265-77. PubMed ID: 25300695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.